tradingkey.logo

Becton Dickinson and Co

BDX
193.960USD
+0.100+0.05%
終値 12/05, 16:00ET15分遅れの株価
55.36B時価総額
32.99直近12ヶ月PER

Becton Dickinson and Co

193.960
+0.100+0.05%

詳細情報 Becton Dickinson and Co 企業名

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Becton Dickinson and Coの企業情報

企業コードBDX
会社名Becton Dickinson and Co
上場日Sep 25, 1963
最高経営責任者「CEO」Mr. Thomas E. Polen
従業員数74000
証券種類Ordinary Share
決算期末Sep 25
本社所在地One Becton Drive
都市FRANKLIN LAKES
証券取引所NYSE Consolidated
United States of America
郵便番号07417-1880
電話番号12018476800
ウェブサイトhttps://www.bd.com/
企業コードBDX
上場日Sep 25, 1963
最高経営責任者「CEO」Mr. Thomas E. Polen

Becton Dickinson and Coの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
761.54K
+0.94%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
54.82K
+16.58%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+21.15%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
16.58K
-0.45%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
6.05K
+659.55%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
761.54K
+0.94%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
54.82K
+16.58%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+21.15%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
16.58K
-0.45%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Medication Delivery Solutions
1.13B
20.55%
Medication Management Solutions
888.00M
16.12%
Pharmaceutical Systems
629.00M
11.42%
Peripheral Intervention
512.00M
9.29%
Specimen Management
470.00M
8.53%
他の
1.88B
34.09%
地域別USD
会社名
収益
比率
United States
3.18B
57.72%
International
2.33B
42.26%
事業別
地域別
事業別USD
会社名
収益
比率
Medication Delivery Solutions
1.13B
20.55%
Medication Management Solutions
888.00M
16.12%
Pharmaceutical Systems
629.00M
11.42%
Peripheral Intervention
512.00M
9.29%
Specimen Management
470.00M
8.53%
他の
1.88B
34.09%

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.32%
T. Rowe Price Investment Management, Inc.
5.69%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.86%
First Eagle Investment Management, L.L.C.
3.50%
他の
69.45%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.32%
T. Rowe Price Investment Management, Inc.
5.69%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.86%
First Eagle Investment Management, L.L.C.
3.50%
他の
69.45%
種類
株主統計
比率
Investment Advisor
48.62%
Investment Advisor/Hedge Fund
35.74%
Research Firm
2.91%
Pension Fund
2.39%
Bank and Trust
1.46%
Hedge Fund
1.42%
Sovereign Wealth Fund
1.36%
Individual Investor
0.60%
Insurance Company
0.32%
他の
5.17%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
2848
265.27M
92.55%
-11.28M
2025Q2
2864
264.72M
92.36%
-14.86M
2025Q1
2897
269.10M
93.89%
-12.90M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
32.17M
11.22%
+4.30M
+15.41%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
16.18M
5.64%
+3.60M
+28.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
15.15M
5.29%
+360.45K
+2.44%
Jun 30, 2025
State Street Investment Management (US)
13.41M
4.68%
-579.46K
-4.14%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
8.79M
3.07%
+3.27M
+59.18%
Jun 30, 2025
MFS Investment Management
7.69M
2.68%
+1.58M
+25.78%
Jun 30, 2025
Geode Capital Management, L.L.C.
6.72M
2.35%
+244.20K
+3.77%
Jun 30, 2025
ClearBridge Investments, LLC
3.80M
1.33%
+321.67K
+9.24%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares U.S. Medical Devices ETF
4.25%
FPA Global Equity ETF
3.12%
Cullen Enhanced Equity Income ETF
3.1%
American Century Focused Large Cap Value ETF
3.04%
iShares Large Cap Value Active ETF
2.72%
First Eagle Global Equity ETF
2.66%
Franklin ClearBridge Enhanced Income ETF
2.66%
T Rowe Price Capital Appreciation Equity ETF
2.65%
Brandes US Value ETF
2.26%
First Trust Indxx Medical Devices ETF
1.92%
詳細を見る
iShares U.S. Medical Devices ETF
比率4.25%
FPA Global Equity ETF
比率3.12%
Cullen Enhanced Equity Income ETF
比率3.1%
American Century Focused Large Cap Value ETF
比率3.04%
iShares Large Cap Value Active ETF
比率2.72%
First Eagle Global Equity ETF
比率2.66%
Franklin ClearBridge Enhanced Income ETF
比率2.66%
T Rowe Price Capital Appreciation Equity ETF
比率2.65%
Brandes US Value ETF
比率2.26%
First Trust Indxx Medical Devices ETF
比率1.92%

配当金

過去5年間の配当金総支払額は 5.54B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
詳細を見る

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Becton Dickinson and Coの上位5名の株主は誰ですか?

Becton Dickinson and Coの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は32.17M株を保有しており、これは全体の11.22%に相当します。
T. Rowe Price Investment Management, Inc.は16.18M株を保有しており、これは全体の5.64%に相当します。
BlackRock Institutional Trust Company, N.A.は15.15M株を保有しており、これは全体の5.29%に相当します。
State Street Investment Management (US)は13.41M株を保有しており、これは全体の4.68%に相当します。
First Eagle Investment Management, L.L.C.は8.79M株を保有しており、これは全体の3.07%に相当します。

Becton Dickinson and Coの株主タイプ上位3種は何ですか?

Becton Dickinson and Coの株主タイプ上位3種は、
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.

Becton Dickinson and Co(BDX)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Becton Dickinson and Coの株式を保有している機関は2848社あり、保有株式の総市場価値は約265.27Mで、全体の92.55%を占めています。2025Q2と比較して、機関の持ち株は0.19%増加しています。

Becton Dickinson and Coの最大の収益源は何ですか?

FY2025Q3において、Medication Delivery Solutions部門がBecton Dickinson and Coにとって最大の収益を生み出しており、その金額は1.13Bで、全収益の20.55%を占めています。
KeyAI